

807 Street 39MC, Phnom Penh, Cambodia
Fenoget Fenofibrate 200mg
Prescription notice
Item may require a valid prescription. Please consult your doctor or pharmacist before using new medication.
Last updated 28/08/2026 at 5:12 PM

807 Street 39MC, Phnom Penh, Cambodia
Indication
Fenoget is a fibrate indicated as an adjunct to dietary measures for the treatment of dyslipidaemia, particularly hypertriglyceridaemia and mixed dyslipidaemia. It lowers triglycerides and raises HDL-cholesterol levels, and may reduce LDL-cholesterol.
Ingredients
- Fenofibrate 200 mg
Direction
Adults: 200 mg once daily with a meal, or as directed by a physician. The dose may be adjusted based on lipid response.
Side effects
- Gastrointestinal: nausea
- abdominal pain
- diarrhea
- flatulence.
- Elevated liver enzymes.
- Myalgia
- myopathy (risk increases with statin co
- therapy).
- Headache.
- Rarely: rhabdomyolysis
- pancreatitis
- cholelithiasis.
Precautions
- Contraindicated in severe renal or hepatic impairment
- gallbladder disease
- and active liver disease.
- Use with caution when combined with statins (increased risk of myopathy and rhabdomyolysis).
- Monitor liver function and serum creatinine during therapy.
- Not for use during pregnancy or breastfeeding.
- May potentiate anticoagulant effect of warfarin — monitor INR.
- Keep out of reach of children.
Indication
Fenoget is a fibrate indicated as an adjunct to dietary measures for the treatment of dyslipidaemia, particularly hypertriglyceridaemia and mixed dyslipidaemia. It lowers triglycerides and raises HDL-cholesterol levels, and may reduce LDL-cholesterol.
Ingredients
- Fenofibrate 200 mg
Direction
Adults: 200 mg once daily with a meal, or as directed by a physician. The dose may be adjusted based on lipid response.
Side effects
- Gastrointestinal: nausea
- abdominal pain
- diarrhea
- flatulence.
- Elevated liver enzymes.
- Myalgia
- myopathy (risk increases with statin co
- therapy).
- Headache.
- Rarely: rhabdomyolysis
- pancreatitis
- cholelithiasis.
Precautions
- Contraindicated in severe renal or hepatic impairment
- gallbladder disease
- and active liver disease.
- Use with caution when combined with statins (increased risk of myopathy and rhabdomyolysis).
- Monitor liver function and serum creatinine during therapy.
- Not for use during pregnancy or breastfeeding.
- May potentiate anticoagulant effect of warfarin — monitor INR.
- Keep out of reach of children.
You may also like
Similar medicines from ឱសថស្ថាន ក្តីស្រឡាញ់



